Menu
GeneBe

rs786201256

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2

The NM_007294.4(BRCA1):c.378A>T(p.Gln126His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q126R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

BRCA1
NM_007294.4 missense

Scores

4
8
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.892
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 15 uncertain in NM_007294.4
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BRCA1NM_007294.4 linkuse as main transcriptc.378A>T p.Gln126His missense_variant 6/23 ENST00000357654.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BRCA1ENST00000357654.9 linkuse as main transcriptc.378A>T p.Gln126His missense_variant 6/231 NM_007294.4 P4P38398-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 26, 2019The p.Q126H variant (also known as c.378A>T), located in coding exon 5 of the BRCA1 gene, results from an A to T substitution at nucleotide position 378. The glutamine at codon 126 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Pathogenic
0.37
D
BayesDel_noAF
Pathogenic
0.29
Cadd
Benign
21
Dann
Uncertain
1.0
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.84
T;T;T;T;D;T;D;T;D;D;T;T;T;D;D;T
M_CAP
Pathogenic
0.76
D
MetaRNN
Uncertain
0.58
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.89
D
MutationAssessor
Uncertain
2.5
M;M;M;M;.;M;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
0.66
D;D;D;D;D;D;D;D;D;N;N;N;N;N
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.2
N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;N
REVEL
Uncertain
0.63
Sift
Benign
0.20
T;D;D;T;D;T;D;T;T;D;D;.;D;D;D;T
Sift4G
Uncertain
0.025
D;D;D;D;D;D;.;.;D;.;D;.;D;.;D;.
Polyphen
1.0, 0.99, 1.0
.;D;.;.;.;D;.;.;.;.;D;.;.;.;.;.
Vest4
0.56
MutPred
0.29
Loss of MoRF binding (P = 0.1022);Loss of MoRF binding (P = 0.1022);Loss of MoRF binding (P = 0.1022);Loss of MoRF binding (P = 0.1022);.;Loss of MoRF binding (P = 0.1022);.;Loss of MoRF binding (P = 0.1022);.;.;Loss of MoRF binding (P = 0.1022);Loss of MoRF binding (P = 0.1022);Loss of MoRF binding (P = 0.1022);.;Loss of MoRF binding (P = 0.1022);Loss of MoRF binding (P = 0.1022);
MVP
0.96
MPC
0.40
ClinPred
0.93
D
GERP RS
3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.24
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-41256202; API